Cecilia Smith-Togobo

Cecilia Smith-Togobo

Auto-generated profile, based on publicly available information

Cecilia Smith-Togobo

Department of Medical Laboratory Sciences,University of Health & Allied Sciences, PMB 31, Ho, Ghana

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in APMIS
Verified
Journal Article
Open access
PDF file
MQMaria del Pilar Quintana
Maria del Pilar Quintana
CSCecilia Smith‐Togobo
Cecilia Smith‐Togobo
AMAnn Moormann
Ann Moormann
LHLars Hviid
Lars Hviid
Burkitt lymphoma (BL) is an aggressive non‐Hodgkin lymphoma. The prevalence of BL is ten‐fold higher in areas with stable transmission of Plasmodium falciparum malaria, where it is the most common childhood cancer, and is referred to as endemic BL (eBL). In addition to its association with exposure to P. falciparum infection, eBL is strongly associated with Epstein–Barr virus (EBV) infection (>90%). This is in contrast to BL as it occurs outside P. falciparum‐endemic areas (sporadic BL), where only a minority of the tumours are EBV‐positive. Although the striking geographical overlap in the distribution of eBL and P. falciparum was noted shortly after the first detailed description of eBL in 1958, the molecular details of the interaction between malaria and eBL remain unresolved. It is furthermore unexplained why exposure to P. falciparum appears to be essentially a prerequisite to the development of eBL, whereas other types of malaria parasites that infect humans have no impact. In this brief review, we summarize how malaria exposure may precipitate the malignant transformation of a B‐cell clone that leads to eBL, and propose an explanation for why P. falciparum uniquely has this capacity.

30 March 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CSCecilia Smith-Togobo
Cecilia Smith-Togobo
RMRichard Mprah
Richard Mprah
EYEvans Adamu Yeboah
Evans Adamu Yeboah
HAHarry Koku Anyidoho
Harry Koku Anyidoho
DADzifa Asigbe
Dzifa Asigbe
Kwabena Obeng DueduKwabena Obeng Duedu
Kwabena Obeng Duedu
Urinary schistosomiasis has long been associated with bladder cancer, but it is still not clear the mechanisms involved. Schistosoma haematobium causes injury and disruptions in the integrity of the urothelium. The cellular and immunologic responses to the infection lead to the formation of granulomata. The ability to use cellular morphological changes to predict the risk of developing bladder cancer following S. haematobium infection is thus important. This study assessed the cellular changes in the urine associated with schistosomiasis and the potential of routine urine being used as a risk predictor of the development of bladder cancer. Urine samples (160) were screened for the presence of S. haematobium ova. Smears stained with the Papanicolaou method were evaluated using light microscopy to determine the cell populations. A high prevalence (39.9%) of urinary schistosomiasis and haematuria (46.9%) was found among the participants. Polymorphonuclear cells, normal and reactive urothelial cells and lymphocytes were characteristic of S. haematobium infection. Squamous metaplastic cells (SMCs) were found in 48% and 47.1% of participants who have had past or current S. haematobium infection respectively, but were not found in participants who had no exposure to S. haematobium. These squamous metaplastic cells are in transition and are prone to malignant transformation when exposed to a carcinogenic agent. There is still a high burden of schistosomiasis in endemic communities in Ghana. by examining urine, one can find metaplastic cells and? dysplastic cells and thus predict cancer in SH-infested patients. Thus, routine urine cytology as a tool to monitor the risk of bladder cancer development is recommended.

16 November 2023 in Future Oncology
Verified
Journal Article
Closed access
GOGeorge Yiadom Osei
George Yiadom Osei
JAJoseph Adu-Amankwaah
Joseph Adu-Amankwaah
SKSelina Koomson
Selina Koomson
SBSolomon Beletaa
Solomon Beletaa
MAMuhammad Khairi Ahmad
Muhammad Khairi Ahmad
SRSiti Razila Abdul Razak
Siti Razila Abdul Razak
Colorectal cancer (CRC) is a significant contributor to cancer mortality worldwide, and the presence of cancer stem cells (CSC) represents a major challenge for achieving effective treatment. miRNA...

30 December 2019 in BMC Cancer
Verified
Journal Article
Open access
PDF file
CSCecilia Smith-Togobo
Cecilia Smith-Togobo
MPMette Ø. Pedersen
Mette Ø. Pedersen
SJSteffen G. Jensen
Steffen G. Jensen
BDBabatunde Duduyemi
Babatunde Duduyemi
RGRichard K. Gyasi
Richard K. Gyasi
LHLars Hviid
Lars Hviid
Background: Endemic Burkitt lymphoma (eBL) is an aggressive B-cell lymphoma, which is a common childhood cancer in areas with intense transmission ofPlasmodium falciparumparasites. Early and accurate diagnosis is a prerequisite for successful therapy, but it optimally involves advanced laboratory investigations. These are technologically demanding, expensive, and often difficult to implement in settings where eBL is prevalent. Diagnosis is thus generally based on clinical assessment and morphological examination of tumour biopsies or fine-needle aspirates (FNAs).Methods: The purpose of the present study was to assess the accuracy of eBL diagnosis at two tertiary hospitals in Ghana. To that end, we studied FNAs from 29 eBL patients and 21 non-eBL lymphoma patients originally diagnosed in 2018. In addition, we examined 111 archival formalin-fixed and paraffin-embedded (FFPE) biopsies from Ghanaian patients originally diagnosed as eBL (N = 55) or non-eBL (N = 56) between 2010 and 2017. Availability-based subsets of samples were subjected to haematoxylin-eosin or Giemsa staining, C-MYC immunohistochemistry, and fluorescence in situ hybridisation (FISH) analysis ofc-mycrearrangements.Results: We found a good correlation between original diagnosis and subsequent retrospective assessment, particularly for FNA samples. However, evidence of intactc-mycgenes and normal C-MYC expression in samples from some patients originally diagnosed as eBL indicates that morphological assessment alone can lead to eBL over-diagnosis in our study area. In addition, several FFPE samples could not be assessed retrospectively, due to poor sample quality. Therefore, the simpler FNA method of obtaining tumour material is preferable, particularly when careful processing of biopsy specimens cannot be guaranteed.Conclusion: We conclude that the accuracy of eBL diagnostic tools available in Ghana is generally adequate, but could be improved by implementation of additional pathology laboratory investigations. Improved attention to adequate preservation of archival samples is recommended.